We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
National Diabetes Audit, CCG Profiles, England - 2011-12: Report 2, A to CAudit, Survey, Other reports and statistics, Official statistics
- Publication Date:
- 28 Nov 2013
- Geographic Coverage:
- England, Wales
- Geographical Granularity:
- NHS Trusts, Primary Care Organisations, Hospital Trusts, Clinical Commissioning Groups, Country, Strategic Health Authorities, Primary Care Trusts, NHS Health Boards, Local Authorities, GP practices, Dental practices, Pharmacies and clinics
- Date Range:
- 01 Jan 2011 to 31 Mar 2012
Local reports - breakdown of report 2 (Complications and Mortality)
In addition to the National reports, the NDA has also produced CCG/LHB profile reports which present key CCG/LHB findings from the 2011-2012 audit for all age groups. The data used to produce the reports is extracted from GP practices in your CCG/LHB and is augmented by secondary care outpatient data and Hospital Episode Statistics and Patient Episode Data for Wales on diabetes related complications. The data is validated, processed and analysed to measure compliance with the National Service Framework (NSF) for Diabetes and NICE quality standards. The analysis contained in the CCG/LHB profile report is benchmarked against the national findings and provides some time trend analysis, allowing you to compare care and treatment results to findings from the 2010-2011 audit. For further information and recommended actions for commissioners please refer to the National Diabetes Audit 2011-2012 Report 2: Complications and Mortality.